| CRCRX | DFREX | CRCRX / DFREX | |
| Total Expense Ratio | 1.93 | 0.18 | 1,072% |
| Annual Report Gross Expense Ratio | 2.08 | 0.21 | 990% |
| Fund Existence | 23 years | 33 years | - |
| Gain YTD | 13.235 | 12.814 | 103% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 225M | 7.06B | 3% |
| Annual Yield % from dividends | 1.35 | 2.56 | 53% |
| Returns for 1 year | 11.75 | 12.55 | 94% |
| Returns for 3 years | 21.36 | 30.37 | 70% |
| Returns for 5 years | -17.10 | 12.53 | -136% |
| Returns for 10 years | -38.40 | 66.43 | -58% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| CAMX | 34.88 | N/A | N/A |
| Cambiar Aggressive Value ETF | |||
| IBTH | 22.33 | -0.03 | -0.13% |
| iShares iBonds Dec 2027 Term Tr ETF | |||
| MSSM | 59.56 | -0.57 | -0.94% |
| Morgan Stanley Pathway Sm-Md Cp Eq ETF | |||
| IQSU | 61.30 | -0.81 | -1.31% |
| NYLI Candriam U.S. Large Cap Equity ETF | |||
| PLTG | 11.49 | -0.49 | -4.09% |
| Leverage Shares 2X Long PLTR Daily ETF | |||